Perfecting Mice Models to Better Understand Prostate Cancer

Dr. Jim Xuan (1999, 2000 and 2002 Research Grants)

Mice are an important part of medical research because they are physiologically very similar to humans and have the same cancer incidence (30 per cent).

By creating genetically modified mice that mimic genetic alterations and human disease progression, scientists can test theories of causes and treatment of prostate cancer. The more closely a mouse model mimics human cancer, the faster it will lead to new treatments.

Dr. Jim Xuan has been awarded three Foundation grants for his work with mice models. In addition to developing new mouse models for prostate cancer, they have created a blood biomarker that helps monitor the initiation and progress of cancer in mice. They have also developed new three-dimensional technology that allows researchers to see what is happening inside the mice. Previously, the only way to evaluate effectiveness of therapy was during autopsy. Now researchers can see the effects of their interventions while mouse models are alive.

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More

Prostate Cancer Canada launches first national program in radioligand therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More


Click here for news archive